Outcomes and complications of trans-vaginal mesh repair using the Prolift™ kit for pelvic organ prolapse at 4 years median follow-up in a tertiary referral centre

Abstract

Our study demonstrates that Prolift™ vaginal mesh surgery offers anatomical cure rates of 89.9 %. A higher rate of de novo recurrence in the non-operated compartment was noted suggesting that surgical correction in one compartment may exacerbate recurrence in other compartments.

Prospective long-term results, complications and risk factors in pelvic organ prolapse treatment with vaginal mesh

“…With respect to the anatomical results, we found a 91,3% of POP correction. This high percentage correlates to what is reported in the literature, ranging from 79 to 96,5% [10,[22][23][24]. The patients in whom there was a prolapse recurrence, they did not need a reoperation, as they remained asymptomatic, unlike other series [25].…”

“…In those articles reporting urinary symptoms, the correction is the most common result [26,27]. Some authors found de novo SUI after the surgery (as well as we did); others reported a worsening of urinary symptoms [22,24], including voiding difficulty [28].…”

“…Early complications reported in the literature include visceral injuries (bladder, rectum), bleeding, hematoma, acute urine retention, fever, mesh infection, thrombophlebitis and urinary tract infection [10,21,24]. In this study, the small rectal perforation could be repaired intraoperatively and the mesh was placed, with no further complications.…”

Perioperative outcomes and prospective patient reported outcome measures for transvaginal mesh surgery

“…High anatomic cure rates following mesh repair with a 5 % mesh exposure rate was noted in a single centre observational study [17]. Mesh exposure rates in our study population were noted to be 4 % (n = 6/135) and 2 % (n = 4/135) reported dyspareunia in our group.…”

Pelvic organ prolapse repair using the Uphold™ Vaginal Support System: a 1-year multicenter study

“…The decrease mostly derived from fewer intraoperative bladder perforations and fewer surgical interventions to treat mesh complications during follow-up. For transvaginal Prolift® mesh, bladder perforation rates range between 0 and 2 % [8][9][10] and for ten different pooled kits this rate was reported to be 0.8 % [11]. A strength of our study was that bladder injury was confirmed or refuted by cystoscopy in nearly all patients and it may be assumed that the occurrence of 1.5 % bladder perforations is accurate.…”